PF-Atlas › Clinical Trials › NCT00999921

Effects of Tamoxifen in Premenopausal Women With Benign Breast Disease Not at High-Risk of Developing Breast Cancer

Tamoxifen · Phase 4

Registry ID

NCT00999921

Phase

Phase 4

Status

Completed

Drug / intervention

Tamoxifen

Sponsor

Medical College and Hospital Kolkata

Start

2008-01

About this trial

Tamoxifen is evaluated in NCT00999921, a Phase 4 idiopathic pulmonary fibrosis study sponsored by Medical College and Hospital Kolkata. Current status: Completed.

View NCT00999921 on ClinicalTrials.gov →

Explore related

All Tamoxifen trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT00999921 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.